Literature DB >> 15778587

The LundADose method for planar image activity quantification and absorbed-dose assessment in radionuclide therapy.

Katarina Sjögreen1, Michael Ljungberg, Karin Wingårdh, David Minarik, Sven-Erik Strand.   

Abstract

A new method for absorbed-dose assessment in radionuclide therapy is presented in this paper. The method is based on activity quantification by the conjugate-view methodology, applied to serial whole-body, anterior-posterior, scintillation-camera scans. The quantification method is an extension of previous studies, and includes separate corrections for attenuation, scatter, and overlapping organs. Further development has now been undertaken to take into account the capabilities of new dual-head camera systems with a built-in X-ray tube for anatomical imaging. Furthermore, the modeling of time-activity data is included, and dosimetric calculations based on the formalism by the Medical Internal Radiation Dose (MIRD) committee. To streamline absorbed-dose assessments for a large number of patient studies, the programs for quantification, image registration, and absorbed-dose calculations have been embedded in an envelop program termed LundADose, where calculations, to a great extent, are performed automatically. Evaluation of the whole-body activity quantification is performed for patients undergoing radioimmunotherapy by monoclonal antibodies labeled with (111)In or (90)Y.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778587     DOI: 10.1089/cbr.2005.20.92

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  4 in total

1.  A gamma camera count rate saturation correction method for whole-body planar imaging.

Authors:  Robert F Hobbs; Sébastien Baechler; Srinivasan Senthamizhchelvan; Andrew R Prideaux; Caroline E Esaias; Melvin Reinhardt; Eric C Frey; David M Loeb; George Sgouros
Journal:  Phys Med Biol       Date:  2010-01-14       Impact factor: 3.609

Review 2.  Human Anti-Oxidation Protein A1M--A Potential Kidney Protection Agent in Peptide Receptor Radionuclide Therapy.

Authors:  Jonas Ahlstedt; Thuy A Tran; Sven-Erik Strand; Magnus Gram; Bo Åkerström
Journal:  Int J Mol Sci       Date:  2015-12-18       Impact factor: 5.923

Review 3.  Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools.

Authors:  Michael Ljungberg; Katarina Sjögreen Gleisner
Journal:  Biomedicines       Date:  2016-11-15

4.  Validation of a SIMIND Monte Carlo modelled gamma camera for Iodine-123 and Iodine-131 imaging.

Authors:  Michaella Morphis; Johan A van Staden; Hanlie du Raan; Michael Ljungberg
Journal:  Heliyon       Date:  2021-05-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.